ocal steroids for triggerfingers

Conditions: Tenosynovitis

Registration Number: NL-OMON26599

Lead Sponsor: Jeroen Bosch Hospital,

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Pending

Sex: Not specified

Target Recruitment: 300

Inclusion Criteria

In order to be eligible to participate in this study, a subject must meet all of the following criteria:
-One or more trigger fingers
-Grade 1-3 trigger finger (according to classification by Quinnell)
-Participation is voluntary and with informed consent

Exclusion Criteria

A potential subject who meets any of the following criteria will be excluded from participation in this study:
-Aged <18
-Congenital trigger finger
-Mentally disabled persons
-Grade 4 trigger finger (according to classification by Quinell)
-Allergy for corticosteroids
-Previous surgical release for triggering
-Previous injection therapy
-History of surgical intervention in the same digit

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary Objective: The primary outcome to be compared is the success rate of Kenalog-40, Kenalog-10 and Depo-Medrol 40 mg/ml in the treatment of a trigger finger. Success rate is defined as no persistent or recurrence of a trigger finger after injection (maximum three injections). We hypothesize that Depo-Medrol 40 mg/ml has the highest success rate (considering rate of persistence, recurrence and amount of injections) and Kenalog-10 is lowest success rate. We expect less difference between Depo-Medrol 40 mg/ml and Kenalog-40 than between Kenalog-40 and Kenalog-10.

Secondary Outcome Measures

Name	Time	Method
-Difference in patient reported outcomes (MHOQ and NRS scores)<br>-Difference in ROM before and two months after injection<br>-Difference in costs<br>-Difference in number and kind of complications<br>-Difference in quinnell primary result after 1, 2 or 3 injection <br>-Difference in after how many injections(1,2 or 3) the treatment is considered a success in the three different research arms.